Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Science Signaling|May 28, 2015
A new strategy to ERADicate HER2-positive breast tumors?Sanjeevani Arora, Erica A Golemis
Gene|June 21, 2016
POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologiesEmmanuelle Nicolas, Erica A Golemis, Sanjeevani Arora
Bioinformatics (Oxford, England)|February 14, 2022
MetaMutationalSigs: comparison of mutational signature refitting results made easyPalash Pandey, Sanjeevani Arora, Gail L Rosen
DNA Repair|April 27, 2010
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cellsSanjeevani Arora, Anbarasi Kothandapani, Kristin Tillison, et al.
Aging Cell|December 9, 2014
Reversible cell cycle inhibition and premature aging features imposed by conditional expression of p16Ink4aAmelie Boquoi, Sanjeevani Arora, Tina Chen, et al.
Frontiers in Genetics|April 19, 2021
RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer TherapyWaleed Iqbal, Elena V Demidova, Samantha Serrao, et al.
Cancers|October 4, 2018
Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander SignalingSanjeevani Arora, Joshua R Heyza, Elaine C Chalfin, et al.
JAMA Network Open|February 29, 2024
Factors Associated With Racial and Ethnic Disparities in Locally Advanced Rectal Cancer OutcomesRebecca M Shulman, Mengying Deng, Elizabeth A Handorf, et al.
Advances in Therapy|August 15, 2019
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid TumorsSanjeevani Arora, Rodion Velichinskii, Randy W Lesh, et al.
Bioengineering & Translational Medicine|October 1, 2025
Metabolic and proteomic signatures differentiate inflammatory phenotypes from cancer and predict treatment response in patient seraGabriel Cutshaw, Elena V Demidova, Philip Czyzewicz, et al.
Pageof 3